RGC (STOCKS)
Regencell Bioscience Holdings Limited Ordinary Shares
$31.220000
+2.200000 (+7.58%)
Prev close: $29.020000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Yat-Gai Au
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $16,729.21M
- Employees
- 10
- P/E (TTM)
- -4,336.11
- P/B (TTM)
- 3,175.99
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $3.16B |
| Benefits Costs and Expenses | $2.95B |
| Costs And Expenses | $2.89B |
| Nonoperating Income/Loss | -$57.80M |
| Operating Expenses | $2.89B |
| Operating Income/Loss | $271.70M |
| Other Operating Income/Expenses | $224.70M |
| Income/Loss Before Equity Method Investments | $189.80M |
| Income/Loss From Continuing Operations After Tax | $112.30M |
| Income/Loss From Continuing Operations Before Tax | $213.90M |
| Income/Loss From Equity Method Investments | $24.10M |
| Income Tax Expense/Benefit | $101.60M |
| Income Tax Expense/Benefit, Deferred | -$600.00K |
| Net Income/Loss | $112.30M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $112.30M |
| Net Income/Loss Available To Common Stockholders, Basic | $112.30M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.72 |
| Diluted Earnings Per Share | $0.72 |
| Basic Average Shares | 156,336,000 |
| Diluted Average Shares | 156,986,000 |
| Assets | $2.84B |
| Current Assets | $463.30M |
| Accounts Receivable | $184.00M |
| Inventory | $22.90M |
| Other Current Assets | $256.40M |
| Noncurrent Assets | $2.38B |
| Fixed Assets | $1.51B |
| Intangible Assets | $43.60M |
| Other Non-current Assets | $822.80M |
| Liabilities | $3.70B |
| Current Liabilities | $561.40M |
| Accounts Payable | $232.20M |
| Other Current Liabilities | $329.20M |
| Noncurrent Liabilities | $3.14B |
| Equity | -$855.80M |
| Equity Attributable To Noncontrolling Interest | $100.00K |
| Equity Attributable To Parent | -$855.90M |
| Liabilities And Equity | $2.84B |
| Net Cash Flow From Operating Activities | $409.90M |
| Net Cash Flow From Operating Activities, Continuing | $409.90M |
| Net Cash Flow From Investing Activities | -$410.60M |
| Net Cash Flow From Investing Activities, Continuing | -$410.60M |
| Net Cash Flow From Financing Activities | -$17.00M |
| Net Cash Flow From Financing Activities, Continuing | -$17.00M |
| Net Cash Flow | -$17.70M |
| Net Cash Flow, Continuing | -$17.70M |
| Comprehensive Income/Loss | $116.10M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $116.10M |
| Other Comprehensive Income/Loss | $3.80M |